Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025npj Antimicrobials and ResistanceOpen Access

Mitigating antimicrobial resistance by innovative solutions in AI (MARISA): a modified James Lind Alliance analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

WWWilliam J. WaldockHTHannah ThouldLCLeonid Chindelevitch

Discussion

Loading...

Member takes

Overview

Modified James Lind Alliance analysis identifies key research priorities in AI and antimicrobial resistance, highlighting major barriers.

Key Points

  • A total of 44 distinct themes were identified related to antimicrobial resistance and artificial intelligence, focusing on priority areas.
  • Top priorities include combination therapy, novel therapeutics, and data acquisition, indicating essential areas for future research.
  • Using a modified James Lind Alliance approach, semi-structured interviews were conducted with eight AI and AMR experts to gather insights.
  • The study highlights the need for improved data access and integration, especially from high-burden regions, to enhance the generalizability of findings.

Cite This Study

Waldock et al. (2025) studied this question.

synapsesocial.com/papers/68c239a3b210217d6477caedhttps://doi.org/10.1038/s44259-025-00150-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Decade Of AI-Accelerated Drug Discovery Against Antimicrobial Resistance (2015–2025): Insights And Future Directions2025 · 2 citations
  2. 2AI-Driven Strategies to Forecast and Combat Antibiotic Resistance2025
  3. 3A Review Delving through Current Challenges in AMR and Using Artificial Intelligence in Dealing with AMR2025
  4. 4MODELLING AND MITIGATING ANTIMICROBIAL RESISTANCE (AMR) THROUGH DATA-DRIVEN SURVEILLANCE, AI-POWERED DRUG DISCOVERY, AND PUBLIC HEALTH INTERVENTION DESIGN2025
  5. 5Advancements in Microbial Drug Discovery: Leveraging AI, CRISPR, and Microbiome Insights to Overcome Antimicrobial Resistance2025